Planta 231, 609621
All published evidence is from animal or in vitro studiesno peer-reviewed human clinical trials have been completed as of 2026
This dosing schedule ensures steady medication levels in your body, maximizing its potential to support weight loss and improve your metabolic health
For example, if someone starts taking it and doesnt see any improvement after 12 weeks, its likely that the prescriber would want to discontinue treatment as it should have started to show some results in this amount of time
Side-by-Side: DAC vs No-DAC | Side Effect | DAC | No-DAC | |---|---|---| | Flushing | Moderate | Mild | | Headache | Mild | Mild | | Water retention | Mild to moderate | Minimal | | Tingling | Reported more | Reported less | | Vivid dreams | Reported less | Reported more | | Insulin sensitivity over time | Higher theoretical concern | Lower | And for the record, here's what CJC-1295 does not typically cause at compounded doses: significant cortisol elevation, significant prolactin elevation, severe hunger spikes (that's GHRP-6's territory), mood changes, acute hypoglycemia, or acromegalic changes
Trends Endocrinol Metabolism: TEM